Pancreatic Cancer Prevention by Phospho-Aspirin

In conclusion, our findings indicate that phospho-aspirin has strong anticancer efficacy in preclinical models of pancreatic cancer, warranting its further evaluation. Cancer Prev Res; 9(7); 624–34. ©2016 AACR.

Source: Cancer Prevention Research - June 29, 2016 Category: Cancer & Oncology Authors: Mattheolabakis, G., Papayannis, I., Yang, J., Vaeth, B. M., Wang, R., Bandovic, J., Ouyang, N., Rigas, B., Mackenzie, G. G. Tags: Research Articles Source Type: research